PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-κB-PTX3 Axis Signaling in Breast Cancer Cells - Sorbonne Université
Article Dans Une Revue International Journal of Molecular Sciences Année : 2022

PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-κB-PTX3 Axis Signaling in Breast Cancer Cells

Justine Chivot
  • Fonction : Auteur
Nathalie Ferrand
  • Fonction : Auteur
Aude Fert
  • Fonction : Auteur
Patrick van Dreden
Romain Morichon

Résumé

Poly (ADP-ribose) polymerase inhibitors (PARPi) are targeted therapies that inhibit PARP proteins which are involved in a variety of cell functions. PARPi may act as modulators of angiogenesis; however, the relationship between PARPi and the vasculogenic mimicry (VM) in breast cancer remains unclear. To determine whether PARPi regulate the vascular channel formation, we assessed whether the treatment with olaparib, talazoparib and veliparib inhibits the vascular channel formation by breast cancer cell lines. Here, we found that PARPi act as potent inhibitors of the VM formation in triple negative breast cancer cells, independently of the BRCA status. Mechanistically, we find that PARPi trigger and inhibit the NF-κB signaling, leading to the inhibition of the VM. We further show that PARPi decrease the expression of the angiogenic factor PTX3. Moreover, PTX3 rescued the PARPi-inhibited VM inhibition. In conclusion, our results indicate that PARPi, by targeting the VM, may provide a new therapeutic approach for triple negative breast cancer.
Fichier principal
Vignette du fichier
Chivot at al IJMS 2022.pdf (2.6 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03924463 , version 1 (05-01-2023)

Identifiants

Citer

Justine Chivot, Nathalie Ferrand, Aude Fert, Patrick van Dreden, Romain Morichon, et al.. PARP Inhibitor Inhibits the Vasculogenic Mimicry through a NF-κB-PTX3 Axis Signaling in Breast Cancer Cells. International Journal of Molecular Sciences, 2022, 23, ⟨10.3390/ijms232416171⟩. ⟨hal-03924463⟩
15 Consultations
26 Téléchargements

Altmetric

Partager

More